Journal of Clinical Epidemiology
Volume 59, Issue 8 , Pages 770-778 , August 2006

Summaries of findings, descriptions of interventions, and information about adverse effects would make reviews more informative

  • Claire Glenton

      Affiliations

    • Norwegian Health Services Research Centre, Pb 7004 St. Olavs Plass, 0130 Oslo, Norway
    • Corresponding Author InformationCorresponding author. Tel.: 4741651658; fax: 4723255040.
    • ,
  • Vigdis Underland

      Affiliations

    • Norwegian Health Services Research Centre, Pb 7004 St. Olavs Plass, 0130 Oslo, Norway
    • ,
  • Michelle Kho

      Affiliations

    • Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
    • ,
  • Victoria Pennick

      Affiliations

    • Institute for Work & Health, 481 University Avenue, Suite 800, Toronto, ON M5G 2E9, Canada
    • ,
  • Andrew D. Oxman

      Affiliations

    • Norwegian Health Services Research Centre, Pb 7004 St. Olavs Plass, 0130 Oslo, Norway

,Accepted 12 December 2005.

References 

  1. Entwistle VA, Sheldon TA, Sowden A, Watt IS. Evidence-informed patient choice. Practical issues of involving patients in decisions about health care technologies. Int J Technol Assess Health Care. 1998;14(2):212–225
  2. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med. 1997;126(5):376–380
  3. The Dissemination of Cochrane Evidence: an inventory of resources that use Cochrane reviews. http://www.cochrane.org/reviews/impact/dissemination.htm; 2004.
  4. Glenton C. Developing patient-centred information for back pain patients. Health Expect. 2002;5:319–329
  5. Coulter A, Entwistle VA, Gilbert D. Informing patients. An assessment of the quality of patient information materials. London: King's Fund; 1998;
  6. Duman M, Farrell C. The Poppi guide: practicalities of producing patient information. London: King's Fund; 2000;
  7. The GRADE Working Group . Grading quality of evidence and strength of recommendations. BMJ. 2005;328:1490–1494
  8. Hagen KB, Hilde G, Jamtvedt G, Winnem M. Bed rest for acute low back pain and sciatica (Cochrane Review). The Cochrane Library, Issue 1, 2003. Oxford: Update Software; 2003;
  9. Deyo RA, Battie M, Beurskens AJ, Bombardier C, Croft P, Koes B, et al. Outcome measures for low back pain research. A proposal for standardized use. Spine. 1998;23(18):2003–2013
  10. Alderson P, Green S, Higgins JPT, editors. Cochrane reviewers' handbook 4.2.2 [updated December 2003]. In: The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons, Ltd.; 2004.
  11. van Tulder M, Furlan A, Bombardier C, Bouter L the Editorial Board of The Cochrane Collaboration Back Review Group. Updated method guidelines for systematic reviews in The Cochrane Collaboration Back Review Group. Spine. 2003;28(12):1290–1299
  12. Oxman AD, Guyatt GH. A consumers guide to subgroup analyses. Ann Intern Med. 1992;116(78):84
  13. Ernst E, Pittler MH. Assessment of therapeutic safety in systematic reviews: literature review. BMJ. 2001;323:546
  14. Ioannidis JP, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA. 2001;285(4):437–443
  15. Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Stat Med. 2002;21:1575–1600
  16. Loke YK, Price D, Herxheimer A, on behalf of the Cochrane Adverse Effects subgroup. Including adverse effects in your review. http://www.dsru.org/wwwboard/latestdraft.pdf; 2005.
  17. Mühlhauser I, Berger M. Evidence-based patient information in diabetes. Diabet Med. 2000;17:823–829
  18. Wills CE, Holmes-Rovner M. Patient comprehension of information for shared treatment decision making: state of the art and future directions. Patient Educ Couns. 2003;50(3):285–290
  19. Epstein RM, Alper BS, Quill TE. Communicating evidence for participatory decision making. JAMA. 2004;291(19):2359–2366
  20. Moxey A, O'Connell D, McGettigan P, Henry D. Describing treatment effects to patients: how they are expressed makes a difference. J Gen Intern Med. 2003;18:948–959
  21. Chalmers RJG, editor. Squeezing skin disease into the cochrane mould. Annual meeting of the cochrane skin group held at the British Association of Dermatologists' House, Fitzroy Square, London; 2000.
  22. Deeks JJ, Higgins JPT, Altman DG. 8.9 Presenting, illustrating and tabulating results. In: Alderson P, Green S, Higgins J, editors. Cochrane reviewers' handbook 4.2.2 [updated December 2003] http://www.cochrane.org/resources/handbook/hbook.htm; 2003.
  23. Moxey A, O'Connell D, McGettigan P, Henry D. Describing treatment effects to patients. J Gen Intern Med. 2003;18(11):948–959
  24. Schünemann HJ, Herrin J, Vist G, Oxman AD, Akl E. The impact of framing on decision making. Oral presentation at XI Cochrane Colloquium, Barcelona 2003.
  25. Oxman A, Guyatt G, Schünemann H on behalf of the Grade Working Group. Grading the quality of evidence and the strength of recommendations. The Cochrane Collaboration Methods Groups Newsletter. 2004;8(June):5–6

PII: S0895-4356(06)00025-4

doi: 10.1016/j.jclinepi.2005.12.011

Journal of Clinical Epidemiology
Volume 59, Issue 8 , Pages 770-778 , August 2006

Article Tools

* Image Usage & Resolution